ATE147265T1 - Verwendung von retinoiden zur umkehr glucocorticoid-induzierter hautatrophie - Google Patents

Verwendung von retinoiden zur umkehr glucocorticoid-induzierter hautatrophie

Info

Publication number: ATE147265T1
Authority: AT; Austria
Prior art keywords: glucocorticoid; retinoids; revert; induced skin; skin atrophy
Prior art date: 1989-08-31

Application number

AT90309510T

Other languages

English (en)

Inventor

Albert M Kligman

James A Mezick

Robert J Capetola

Original Assignee

Ortho Pharma Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-08-31

Filing date

1990-08-30

Publication date

1997-01-15

1990-08-30 Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp

1997-01-15 Application granted granted Critical

1997-01-15 Publication of ATE147265T1 publication Critical patent/ATE147265T1/de

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/07—Retinol compounds, e.g. vitamin A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Laminated Bodies (AREA)
Medicinal Preparation (AREA)
Saccharide Compounds (AREA)
Dental Preparations (AREA)
Pens And Brushes (AREA)

AT90309510T 1989-08-31 1990-08-30 Verwendung von retinoiden zur umkehr glucocorticoid-induzierter hautatrophie ATE147265T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US07/401,362 US5019569A (en)	1986-11-03	1989-08-31	Reversal of glucocorticoid-induced skin atrophy

Publications (1)

Publication Number	Publication Date
ATE147265T1 true ATE147265T1 (de)	1997-01-15

Family

ID=23587438

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT90309510T ATE147265T1 (de)	1989-08-31	1990-08-30	Verwendung von retinoiden zur umkehr glucocorticoid-induzierter hautatrophie

Country Status (13)

Country	Link
US (1)	US5019569A (de)
EP (1)	EP0415766B1 (de)
JP (1)	JP3061628B2 (de)
AT (1)	ATE147265T1 (de)
AU (1)	AU634807B2 (de)
DE (1)	DE69029625T2 (de)
DK (1)	DK0415766T3 (de)
ES (1)	ES2098253T3 (de)
GR (1)	GR1000723B (de)
IE (1)	IE903154A1 (de)
PT (1)	PT95150B (de)
SG (1)	SG50453A1 (de)
ZA (1)	ZA906931B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5051449A (en) *	1991-02-27	1991-09-24	Kligman Albert M	Treatment of cellulite with retinoids
US5254343A (en) *	1991-03-19	1993-10-19	Bristol-Myers Squibb Company	Reduction of cutaneous atrophy
US5268176A (en) *	1991-07-22	1993-12-07	Avon Products, Inc.	Method and compositions for the non-invasive treatment of telangiectasia
EP0625045A4 (de) *	1992-02-07	1995-01-18	Albert M Kligman	Verfahren zur behandlung von entzündlichen dermatosen.
EP0659080B1 (de) *	1992-09-11	2001-07-11	BROWN, Sandra	Verfahren zur behandlung von haarausfall
US6344448B1 (en)	1992-09-11	2002-02-05	Stb Family Limited Partnership	Composition for the treatment of hair loss
CA2129773C (en)	1993-09-02	2007-05-01	Michael Klaus	Aromatic carboxylic acid derivatives
US6380255B1 (en)	1995-06-07	2002-04-30	Karo Bio Ab	Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds
US5837224A (en) *	1996-01-19	1998-11-17	The Regents Of The University Of Michigan	Method of inhibiting photoaging of skin
UA48212C2 (uk) *	1996-01-31	2002-08-15	Сергей Дмітрієвіч БУРЛАКОВ	Антиглюкокортикоїдний лікарський засіб
FR2760362B1 (fr)	1997-03-10	2000-08-11	Vitasterol	Utilisation cosmetique ou dermatologique de steroides 7-hydroxyles
US6008254A (en) *	1997-05-09	1999-12-28	Kligman; Douglas E.	Method of treating skin disorders with high-strength tretinoin
US8338648B2 (en) *	2004-06-12	2012-12-25	Signum Biosciences, Inc.	Topical compositions and methods for epithelial-related conditions
NO326950B1 (no) *	2006-09-20	2009-03-16	Pharma Medico Res Ltd	Kombinasjon av et glukokortikoid og et β-syklodekstrin konjugert vitamin A derivat-kompleks
US11957753B2 (en)	2010-11-22	2024-04-16	Bausch Health Ireland Limited	Pharmaceutical formulations containing corticosteroids for topical administration
US8809307B2 (en)	2010-11-22	2014-08-19	Dow Pharmaceutical Sciences, Inc.	Pharmaceutical formulations containing corticosteroids for topical administration
CN108282998B (zh)	2015-06-18	2021-07-06	凡利亚药品北美公司	用于治疗银屑病的包含皮质类固醇和类视黄醇的局部组合物
US11311482B2 (en)	2017-05-12	2022-04-26	Bausch Health Us, Llc	Topical compositions and methods for treating skin diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3729568A (en) *	1969-09-23	1973-04-24	Johnson & Johnson	Acne treatment
US4126693A (en) *	1975-11-03	1978-11-21	Johnson & Johnson	Retinoic acid derivatives in the treatment of acne
US4487782A (en) *	1982-03-26	1984-12-11	Ortho Pharmaceutical Corporation	Topical treatment of non-inflammatory acne
US4889847A (en) *	1986-11-03	1989-12-26	Ortho Pharmaceutical Corporation	Prevention of glucocorticoid-induced skin atrophy
EP0357646B1 (de) *	1987-04-06	1995-03-22	Daltex Medical Sciences, Inc.	Behandlung gealterter haut mit oraler 13-cis-retinsäure

1989
- 1989-08-31 US US07/401,362 patent/US5019569A/en not_active Expired - Lifetime
1990
- 1990-08-28 GR GR900100644A patent/GR1000723B/el not_active IP Right Cessation
- 1990-08-30 ZA ZA906931A patent/ZA906931B/xx unknown
- 1990-08-30 ES ES90309510T patent/ES2098253T3/es not_active Expired - Lifetime
- 1990-08-30 SG SG1996001775A patent/SG50453A1/en unknown
- 1990-08-30 AU AU61987/90A patent/AU634807B2/en not_active Expired
- 1990-08-30 DK DK90309510.7T patent/DK0415766T3/da active
- 1990-08-30 EP EP90309510A patent/EP0415766B1/de not_active Expired - Lifetime
- 1990-08-30 DE DE69029625T patent/DE69029625T2/de not_active Expired - Lifetime
- 1990-08-30 JP JP2226777A patent/JP3061628B2/ja not_active Expired - Lifetime
- 1990-08-30 IE IE315490A patent/IE903154A1/en unknown
- 1990-08-30 PT PT95150A patent/PT95150B/pt not_active IP Right Cessation
- 1990-08-30 AT AT90309510T patent/ATE147265T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
JP3061628B2 (ja)	2000-07-10
EP0415766B1 (de)	1997-01-08
PT95150A (pt)	1991-05-22
US5019569A (en)	1991-05-28
AU6198790A (en)	1991-03-07
DE69029625D1 (de)	1997-02-20
DE69029625T2 (de)	1997-05-28
IE903154A1 (en)	1991-03-13
PT95150B (pt)	1997-06-30
SG50453A1 (en)	1998-07-20
GR1000723B (el)	1992-11-23
JPH03141218A (ja)	1991-06-17
EP0415766A3 (en)	1992-04-08
ES2098253T3 (es)	1997-05-01
DK0415766T3 (da)	1997-01-27
GR900100644A (en)	1991-12-30
AU634807B2 (en)	1993-03-04
EP0415766A2 (de)	1991-03-06
ZA906931B (en)	1992-05-27

Legal Events

Date	Code	Title	Description
1997-06-15	UEP	Publication of translation of european patent specification
2010-11-15	EELA	Cancelled due to lapse of time

Publication	Publication Date	Title
ATE147265T1 (de)	1997-01-15	Verwendung von retinoiden zur umkehr glucocorticoid-induzierter hautatrophie
MX9203338A (es)	1992-09-01	Nuevos derivados del oxico a_nor-esteroide-3-carboxilico.
ATE109352T1 (de)	1994-08-15	Heilung von wunden.
IE862404L (en)	1987-03-10	Hydroxamic acid derivatives
ES553821A0 (es)	1988-02-16	Un procedimiento para la preparacion de nuevas azetidinonas sustituidas.
FI950467A7 (fi)	1995-03-31	Terfenadiinin metaboliitit ja niiden optisesti puhtaat isomeerit aller gisten sairauksien hoitamiseksi
EP0266992A3 (de)	1990-05-16	Verhütung von glukocorticoid-induzierter Hautatrophie
MY106263A (en)	1995-04-29	Method for the treatment or prevention of intrinsically aged skin with retinoids
DE69002697D1 (de)	1993-09-16	Carboplatinzusammensetzung.
FI891986A7 (fi)	1989-04-26	Farmaseuttiset koostumukset psoriasiksen hoitoon
DE69230224D1 (de)	1999-12-02	Potenzierung von nmda-antagonisten
DE69419954D1 (de)	1999-09-16	Arzneimittel zur Behandlung von Hauterkrankungen
LV10391A (lv)	1995-02-20	Alkilfosforskabes savienojumu izmantosana psoriazes tipa slimibu arstesanai
DE69101755D1 (de)	1994-05-26	Verwendung von Phosphomycin pharmazeutisch akzeptierbare Salze als topisches Wundheilungsmittel.
ATE137225T1 (de)	1996-05-15	Dihydrochinolin nmda antagonisten
ATE58521T1 (de)	1990-12-15	Lysinsalz der 4-biphenylessigsaeure und es enthaltende augenheilmittel.
AU7649891A (en)	1991-11-21	Heterocyclic-nmda antagonists
ES2062313T3 (es)	1994-12-16	13-bromo- y 13,14-dibromo-ergolinas, a su preparacion y a su utilizacion en medicamentos.
YU2394A (sh)	1996-10-18	Lizin so 6-hloro-5-fluoro-3-(-2-tenoil)-2-oksindol-1-karboksamida
PT878195E (pt)	2002-09-30	Utilizacao de um composto 2-aroil-3-arilbenzo(b)tiofeno para a reducao de fibrinogenio
FR2576015B1 (fr)	1987-02-13	Esters 4-n-pentylphenyliques mesomorphes d'acides 4'-(trans-4''-n-alcoylcyclohex-2-enoyloxy) benzoiques
SE8503186D0 (sv)	1985-06-26	Sett vid indunstning av avlutar
IT8647570A0 (it)	1986-01-24	Composizione farmaceutica comprendente trometamina per il trattamento per via topica dell'acne giovanile
ES2009463A6 (es)	1989-09-16	Procedimiento de preparacion de derivados de 2-propanol.
BR1100204A (pt)	2000-08-01	Composição farmacêutica para tratar esquizofrenia